SCORE Act

HR1422 — Enhanced Iran Sanctions Act of 2025

Targets Iran's energy revenue through global sanctions. This bill would create a broad sanctions framework to punish foreign persons who process, export, or sell Iran-origin oil, condensates, gas, LNG, or petrochemical products. It pairs blocking of assets and visa bans with ownership-based triggers, waivers, humanitarian carve-outs, and new reporting to limit Iran's access to energy markets and finance for weapons and terrorism. - Foreign energy firms and financial institutions would face blocking of property and bans on transactions if they knowingly handle Iran-origin energy or are 50% or more owned by such actors. Associated aliens could become inadmissible and have visas revoked. - Maritime operators, insurers, flag registries, and LNG pipeline facilities would be exposed to sanctions risk when linked to Iran-origin shipments, though safety-of-crew rules and specific exemptions for imports remain. - Humanitarian organizations would keep explicit exemptions for agricultural commodities, food, medicine, medical devices, and humanitarian assistance to avoid disrupting aid. - U.S. agencies and private companies would see new duties: an interagency working group and multilateral contact group would coordinate enforcement, and private-sector reporting would be required to flag evasion and proceeds from intercepted Iran-origin energy sales.

HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.

HR909 — Crime Victims Fund Stabilization Act of 2025

Would make the False Claims Act apply to deposits to the Crime Victims Fund through FY2029. It would also require an Inspector General audit that sets the audit's scope, timing, and recipients, and the measure is titled the Crime Victims Fund Stabilization Act of 2025. - Entities that make deposits to the Crime Victims Fund would be subject to the False Claims Act (31 U.S.C. 3729–3731) for deposits from enactment through FY2029. - An Inspector General audit would examine the Crime Victims Fund and the bill would set the audit's scope, timing, and who receives the report.

HRES166 — Expressing support for the Iranian people's desires for a democratic, secular, and nonnuclear Republic of Iran, and condemning the Iranian regime's terrorism, regional proxy war, internal suppression, and for other purposes.

Supports the Iranian people's desire for a democratic, secular, and nonnuclear republic. This resolution would condemn the Islamic Republic for terrorism, regional proxy wars, weapons transfers, and domestic repression, and it urges Western nations to sustain sanctions and protect Iranian political refugees. - Iranian protesters and resistance: Affirms that Iranians should determine their political future by vote and highlights major protests led by women and youth. - Victims and minorities inside Iran: Recalls alleged abuses including executions during the first four months of Masoud Pezeshkian's presidency, citing over 500 prisoners killed and at least 17 women, and names repression of Kurds, Baluchis, Arabs, Christians, Jews, Baha'is, Zoroastrians, and Sunni Muslims. - Regional security and trade: Characterizes Iran as a source of terrorism and instability, accusing it of funding proxies and supplying weapons, missiles, and drones that threaten ships, Red Sea trade, and U.S. forces. - Allies and refugees: Urges Western governments to hold the regime accountable with ongoing sanctions, support the Iranian opposition and the Ten-Point Plan for the Future of Iran, and work with Albania to protect political refugees at Ashraf 3 under the 1951 Geneva Convention and the European Convention on Human Rights.

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR979 — AM Radio for Every Vehicle Act of 2025

This bill would require AM broadcast capability to be installed as standard equipment in passenger motor vehicles. It focuses on driver-accessible AM reception, allows digital AM audio to count for compliance, and links vehicle AM capability to emergency alerting through IPAWS. - Drivers and households: Built-in, driver-accessible AM reception would make it easier for people to get local AM stations and emergency alerts from their vehicles. The bill allows devices that receive digital AM to meet the requirement. - Vehicle manufacturers: The Department of Transportation would need to issue a rule within 1 year, with a general compliance deadline no later than 2 years after the rule is issued. Small manufacturers that produced no more than 40,000 passenger vehicles in 2022 would get at least 4 years to comply. - Oversight and emergency systems: States would be barred from imposing their own AM-access rules. The bill mandates interim labels and pricing protections for cars without AM, authorizes civil penalties and DOJ injunctions for violations, requires a GAO study and a congressional briefing within 1 year, and includes an 8-year sunset for the authority.